Enviracor J-5 (Canada)This page contains information on Enviracor J-5 for veterinary use.
The information provided typically includes the following:
- Enviracor J-5 Indications
- Warnings and cautions for Enviracor J-5
- Direction and dosage information for Enviracor J-5
Enviracor J-5This treatment applies to the following species:
Escherichia Coli Bacterin J-5 Strain
For veterinary use only
Enviracor® J-5 Bacterin is recommended for use in healthy dairy cattle as an aid in the control of clinical signs associated with E. coli mastitis. For effective mastitis control this product should be used in conjunction with acceptable good management practices.
Directions For Use
Shake well. Three doses are required. Administer each 5-mL dose subcutaneously in the neck, using aseptic technique. Vaccinate cows or heifers at both 7 and 8 months of gestation followed by the third dose within two weeks postpartum. Use entire contents when first opened.
PrecautionsStore at 2°-7° C. Do not freeze. No milk discard is required. Do not vaccinate within 60 days before slaughter. Local swelling occasionally occurs and may persist at the injection site. In case of anaphylactoid reactions, epinephrine should be administered immediately.
®Registered trade-mark of Pharmacia & Upjohn Company LLC; Pfizer Canada Inc. licensee.
For technical assistance 1-800-461-0917.
U.S. Vet Licence No. 357
Manufactured by: PHL Associates, Inc., Davis, CA USA 95616
Distributed in Canada by: Pfizer Animal Health, Pfizer Canada Inc., Kirkland QC H9J 2M5
NAC No.: 11982843
16,740 TRANS-CANADA HIGHWAY, KIRKLAND, QC, H9H 4M7
|Technical Services Canada:||800-461-0917|
|Technical Services USA:||800-366-5288|
|Every effort has been made to ensure the accuracy of the Enviracor J-5 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-02-06